000 01274 a2200361 4500
005 20250515081222.0
264 0 _c20080613
008 200806s 0 0 eng d
022 _a0928-1231
024 7 _a10.1007/s11096-007-9152-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiguel, Ramón San
245 0 0 _aMeasuring health-related quality of life in drug clinical trials: is it given due importance?
_h[electronic resource]
260 _bPharmacy world & science : PWS
_cApr 2008
300 _a154-60 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Systematic Review
650 0 4 _aClinical Trials as Topic
650 0 4 _aEconomics, Pharmaceutical
650 0 4 _aHealth Status
650 0 4 _aHumans
650 0 4 _aPersonality Inventory
650 0 4 _aPsychometrics
650 0 4 _aQuality of Life
650 0 4 _aSickness Impact Profile
650 0 4 _aSurveys and Questionnaires
650 0 4 _aTreatment Outcome
700 1 _aLópez-González, Ana María
700 1 _aSanchez-Iriso, Eduardo
700 1 _aMar, Javier
700 1 _aCabasés, Juan M
773 0 _tPharmacy world & science : PWS
_gvol. 30
_gno. 2
_gp. 154-60
856 4 0 _uhttps://doi.org/10.1007/s11096-007-9152-9
_zAvailable from publisher's website
999 _c17251805
_d17251805